Clinical Trials Browser

Phase 2 × INDUSTRY × loncastuximab tesirine × Clear all

NCT05144009 2025-01-30

LOTIS-9

Phase 2 Terminated

41 enrolled 19 charts

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT04699461 2023-10-23

LOTIS-6

Phase 2 Terminated

6 enrolled 9 charts

Lymphoma, Lymphoma, Follicular

NCT03589469 2023-08-29

LOTIS-2

Phase 2 Completed

145 enrolled 24 charts 1 FDA

Diffuse Large B-Cell Lymphoma Refractory